title: Hydroxychloroquine Screening Alert: Change is in the Wind.
abstract: Recent studies have changed the management of hydroxychloroquine retinopathy. This editorial outlines a new standard. Estimate dose by real weight, staying below 5 mg/kg. Asian patients may show initial damage outside the parafovea. Renal disease, maculopathy, and tamoxifen are major risk factors. Proper screening allows long usage and avoids bull's eye retinopathy.
authors.forename: Michael F
authors.initials: MF
authors.lastname: Marmor
mesh_terms: D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004596:Electroretinography; D005451:Fluorescein Angiography; D005654:Fundus Oculi; D014943:Global Health; D006801:Humans; D006886:Hydroxychloroquine / Q000008:administration & dosage / Q000009:adverse effects*; D015994:Incidence; D012160:Retina / Q000187:drug effects / Q000473:pathology; D012164:Retinal Diseases / Q000139:chemically induced / Q000175:diagnosis / Q000453:epidemiology; D012307:Risk Factors; D041623:Tomography, Optical Coherence; D014794:Visual Fields
chemical_list: D018501:Antirheumatic Agents; D006886:Hydroxychloroquine